10-Q: Butterfly Network Reports Q1 2024 Results, Revenue Up 14.1% Year-Over-Year

Butterfly Network's Q1 2024 results show a 14.1% increase in revenue compared to the same period last year, driven by higher device sales.

Summary

• Butterfly Network reported a net loss of $21.8 million for the first quarter of 2024, compared to a net loss of $33.5 million in the same period of 2023.
• Total revenue for the quarter was $17.7 million, a 14.1% increase from $15.5 million in Q1 2023.
• Product revenue increased by 27.6% to $11.3 million, while software and other services revenue decreased by 4.0% to $6.4 million.
• The company's operating expenses decreased by 25.5% to $32.9 million, primarily due to reductions in research and development and other expenses.
• Units fulfilled increased by 21.8% year-over-year, indicating growth in device sales.
• The company's cash and cash equivalents stood at $112.7 million as of March 31, 2024.
• Butterfly Network expects its current cash to fund operations for at least the next twelve months and anticipates raising capital before 2026.

Sentiment

Score: 5

Explanation: The document presents mixed results. While revenue increased and operating expenses decreased, the company still reported a significant net loss and anticipates needing to raise capital. The decrease in software revenue is also a concern. The sentiment is neutral to slightly negative.

Positives

• The company experienced a significant increase in product revenue, driven by higher device sales and the launch of the iQ3 probe.
• Operating expenses were reduced by 25.5%, primarily due to cost-cutting measures in R&D and other areas.
• The net loss improved substantially compared to the same quarter last year.
• Units fulfilled increased by 21.8%, indicating strong growth in device sales.
• The company has sufficient cash to fund operations for at least the next twelve months.

Negatives

• Software and other services revenue decreased by 4.0% year-over-year.
• The company continues to operate at a loss, with a net loss of $21.8 million for the quarter.
• Software and other services mix decreased by 6.7 percentage points, to 36.1% due to increased device sales.
• The company anticipates needing to raise capital before reaching profitability.

Risks

• The company's future growth depends on its ability to attract and retain customers.
• The company's business could be harmed if it fails to manage its growth effectively.
• The company's projections are subject to risks, assumptions, estimates, and uncertainties.
• The company is subject to a variety of U.S. and foreign laws, which are subject to change and could adversely affect its business.
• The company faces competition from other companies marketing or developing ultrasound imaging devices.
• The company's ability to maintain the listing of its Class A common stock on the New York Stock Exchange is a risk.
• Economic downturns and political and market conditions beyond the company's control could adversely affect its business.

Future Outlook

The company expects its current cash to fund operations for at least the next twelve months and anticipates raising capital before 2026, potentially through non-dilutive means like grants or debt, followed by equity if necessary. They expect software revenue as a percentage of total revenue to remain flat or decrease in 2024 due to the launch of the iQ3 device.

Management Comments

• Management believes the company's cash and cash equivalents will be sufficient to fund operations for at least the next twelve months.
• Management expects to continue to invest in the business to grow revenue.
• Management plans to first seek non-dilutive capital before potentially raising equity.

Industry Context

The company operates in the competitive medical imaging market, facing established players with greater resources. The focus on portable, affordable ultrasound technology positions Butterfly Network to potentially disrupt traditional imaging practices, particularly in point-of-care settings. The shift towards software and services is a common trend in the medical technology industry, aiming for recurring revenue streams and higher margins.

Comparison to Industry Standards

• Butterfly Network's revenue growth of 14.1% is a positive sign, but it is important to compare this to other medical device companies in the ultrasound space, such as Philips, GE Healthcare, and Siemens Healthineers, which typically have much larger revenue bases and more established market positions.
• The company's focus on a handheld, chip-based ultrasound device is a differentiator, but its success depends on its ability to gain market share against established competitors.
• The decrease in software and services revenue mix is a concern, as this is typically a higher-margin area for medical technology companies. Companies like Teladoc Health and Dexcom have demonstrated the value of recurring revenue models in healthcare.
• The company's operating expenses are still high relative to its revenue, indicating a need for further cost management. Companies like Intuitive Surgical have achieved profitability through a combination of revenue growth and cost control.
• The company's cash position of $112.7 million is relatively low compared to larger competitors, highlighting the need for additional capital raises in the future.

Legal Proceedings

• The company is involved in litigation and legal matters from time to time, which have arisen in the normal course of business.
• A putative class action lawsuit, styled Rose v. Butterfly Network, Inc., et al. was filed in the United States District Court for the District of New Jersey.
• A stockholder derivative action, styled Koenig v. Todd M. Fruchterman, et al. was filed in the United States District Court for the District of Delaware.
• A stockholder derivative action, styled Bhavsar v. Todd M. Fruchterman, et al. was filed in the United States District Court for the District of Delaware.

Stakeholder Impact

• Shareholders may be concerned about the continued net losses and the need for future capital raises.
• Employees may be affected by potential future cost-cutting measures.
• Customers may benefit from the company's innovative products and services.
• Suppliers may be impacted by the company's inventory purchase commitments.
• Creditors may be impacted by the company's financial performance and ability to repay debts.

Next Steps

• The company plans to continue investing in its business to grow revenue.
• The company expects to raise capital before reaching profitability.
• The company will continue to monitor its financial performance and make strategic decisions.

Key Dates

Keywords

ultrasound, medical devices, digital health, software, SaaS, healthcare, imaging, Butterfly Network, financial results, revenue, operating expenses, net loss